4.6 Article

Propofol Attenuated Acute Kidney Injury after Orthotopic Liver Transplantation via Inhibiting Gap Junction Composed of Connexin 32

期刊

ANESTHESIOLOGY
卷 122, 期 1, 页码 72-86

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ALN.0000000000000448

关键词

-

资金

  1. National Natural Science Foundation of China (Beijing, China) [81170449, 81401628]
  2. Natural Science Foundation of Guangdong Province, China (Guangzhou, Guangdong Province, China) [S2011020002780]
  3. 985 project (Beijing, China) [82000-1188190]

向作者/读者索取更多资源

Background: Postliver transplantation acute kidney injury (AKI) severely affects patient survival, whereas the mechanism is unclear and effective therapy is lacking. The authors postulated that reperfusion induced enhancement of connexin32 (Cx32) gap junction plays a critical role in mediating postliver transplantation AKI and that pretreatment/precondition with the anesthetic propofol, known to inhibit gap junction, can confer effective protection. Methods: Male Sprague-Dawley rats underwent autologous orthotopic liver transplantation (AOLT) in the absence or presence of treatments with the selective Cx32 inhibitor, 2-aminoethoxydiphenyl borate or propofol (50 mg/kg) (n = 8 per group). Also, kidney tubular epithelial (NRK-52E) cells were subjected to hypoxia-reoxygenation and the function of Cx32 was manipulated by three distinct mechanisms: cell culture in different density; pretreatment with Cx32 inhibitors or enhancer; Cx32 gene knock-down (n = 4 to 5). Results: AOLT resulted in significant increases of renal Cx32 protein expression and gap junction, which were coincident with increases in oxidative stress and impairment in renal function and tissue injury as compared to sham group. Similarly, hypoxia-reoxygenation resulted in significant cellular injury manifested as reduced cell growth and increased lactate dehydrogenase release, which was significantly attenuated by Cx32 gene knock-down but exacerbated by Cx32 enhancement. Propofol inhibited Cx32 function and attenuated post-AOLT AKI. In NRK-52E cells, propofol reduced posthypoxic reactive oxygen species production and attenuated cellular injury, and the cellular protective effects of propofol were reinforced by Cx32 inhibition but cancelled by Cx32 enhancement. Conclusion: Cx32 plays a critical role in AOLT-induced AKI and that inhibition of Cx32 function may represent a new and major mechanism whereby propofol reduces oxidative stress and subsequently attenuates post-AOLT AKI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Anesthesiology

Pharmacological and clinical implications of local anaesthetic mixtures: a narrative review

C. C. Nestor, C. Ng, P. Sepulveda, M. G. Irwin

Summary: Mixing long- and short-acting local anaesthetics to hasten onset and extend duration may lead to ineffective solutions or potential harm due to pharmacokinetic principles; many local anaesthetic adjuncts are not approved for use, which can result in adverse events, and pharmaceutical compatibility needs to be confirmed before administration.

ANAESTHESIA (2022)

Review Anesthesiology

Peri-operative neurological monitoring with electroencephalography and cerebral oximetry: a narrative review

C. K. E. Chung, C. C. M. Poon, M. G. Irwin

Summary: Surgery and anesthesia can cause stress to the brain, and monitoring with electroencephalography and cerebral oximetry can help assess anesthesia depth and cerebral metabolic activity. However, research results on the ability of these monitors to alleviate peri-operative neurocognitive complications have been contradictory. Understanding the changes in electroencephalography under anesthesia and those associated with aging is important for correctly interpreting anesthesia depth indices. Cerebral oximetry is useful for detecting cerebral desaturation and identifying higher-risk patients. An algorithm-based approach may be most effective in managing cerebral desaturation events.

ANAESTHESIA (2022)

Article Cardiac & Cardiovascular Systems

lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth

Haobo Li, Lena E. Trager, Xiaojun Liu, Margaret H. Hastings, Chunyang Xiao, Justin Guerra, Samantha To, Guoping Li, Ashish Yeri, Rodosthenis Rodosthenous, Michael G. Silverman, Saumya Das, Amrut V. Ambardekar, Michael R. Bristow, Juan Manuel Gonzalez-Rosa, Anthony Rosenzweig

Summary: This study identifies a novel pathway, lncExACT1-DCHS2, that regulates cardiac hypertrophy and cardiomyogenesis. lncExACT1-DCHS2 acts as a master switch toggling the heart between physiological and pathological growth to determine functional outcomes, providing a potentially tractable therapeutic target for harnessing the beneficial effects of exercise.

CIRCULATION (2022)

Letter Anesthesiology

Drug mixtures and infusion technology: replies

C. C. Nestor, P. Sepulveda, M. G. Irwin

ANAESTHESIA (2022)

Letter Anesthesiology

What version of Hell's Kitchen? A reply

C. C. Nestor, P. Sepulveda, M. G. Irwin

ANAESTHESIA (2022)

Article Cell Biology

MicroRNA-503 Exacerbates Myocardial Ischemia/Reperfusion Injury via Inhibiting PI3K/Akt- and STAT3-Dependent Prosurvival Signaling Pathways

Yanjing He, Yin Cai, Tianhao Sun, Liangqing Zhang, Michael G. Irwin, Aimin Xu, Zhengyuan Xia

Summary: Acute myocardial infarction is a leading cause of death worldwide. Restoration of blood flow may lead to ischemia/reperfusion injury. This study found that miR-503 exacerbated I/R injury via inactivation of PI3K/Akt and STAT3 pathways.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Anesthesiology

Position statement from the Editors of Anaesthesia on equity, diversity and inclusion

S. Agarwal, K. El-Boghdadly

Summary: This position statement highlights the importance of prioritising equity, diversity and inclusion in anaesthesia and medicine. The Anaesthesia Editors outline their policies and practices to achieve these goals, including transparent recruitment practices and removing barriers to leadership roles. They commit to regularly reviewing and improving their policies and embracing equity, diversity and inclusion.

ANAESTHESIA (2022)

Letter Emergency Medicine

Repurposing Polyvinyl Chloride Pipes in the Emergency Department for COVID-19

Wei Deng, Steven Wang, Rex Pui Kin Lam, Timothy Hudson Rainer, Michael Garnet Irwin

ANNALS OF EMERGENCY MEDICINE (2022)

Review Pharmacology & Pharmacy

Opioid MOP receptor agonists in late-stage development for the treatment of postoperative pain

Qiu Qiu, Joshua C. J. Chew, Michael G. Irwin

Summary: Opioids are still important in postoperative analgesia, but the focus is on using them as part of multimodal regimens to avoid their complete use. The development of new drugs with more favorable adverse effect profiles may increase safety while maintaining efficacy.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Article Anesthesiology

Morphological specificity analysis of an image-based 3D model of airway filling in a difficult airway

Wendong Chen, Li Ma, Jianlin Shao, Chun Bi, Yuchen Xie, Shuangyan Zhao

Summary: This study analyzed the position-specific morphological changes of the upper airway and assessed their impact on difficult airway during intubation. The results showed that difficult airway had lower upper airway filling volumes compared to normal airway. Furthermore, the airway volume increased as the body position changed.

BMC ANESTHESIOLOGY (2022)

Review Anesthesiology

Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review

L. M. Hughes, M. G. Irwin, C. C. Nestor

Summary: Propfol-remifentanil-based total intravenous anaesthesia is commonly used in clinical practice due to its favorable pharmacokinetic profile. However, interruption in remifentanil supply presents an opportunity to explore alternative opioids and consider adjuncts to propofol-based anaesthesia. This article provides an overview of different opioids and their administration methods, as well as the role of non-opioid adjuncts in total intravenous anaesthesia.

ANAESTHESIA (2023)

Article Anesthesiology

Postoperative pulmonary complications in older patients undergoing elective surgery with a supraglottic airway device or tracheal intubation

L. Q. Yang, L. Zhu, X. Shi, C. H. Miao, H. B. Yuan, Z. Q. Liu, W. D. Gu, F. Liu, X. X. Hu, D. P. Shi, H. W. Duan, C. Y. Wang, H. Weng, Z. L. Huang, L. Z. Li, Z. Z. He, J. Li, Y. P. Hu, L. Lin, S. T. Pan, S. H. Xu, D. Tang, D. I. Sessler, J. Liu, M. G. Irwin, W. F. Yu, POLMA-EP Investigators

Summary: In a clinical study, it was found that using a supraglottic airway device rather than a tracheal tube can reduce postoperative pulmonary complications in older patients undergoing non-cardiothoracic surgery under general anesthesia.

ANAESTHESIA (2023)

Article Anesthesiology

Aerosol generation with the use of positive pressure ventilation via supraglottic airway devices: an observational study

W. Deng, C. C. Nestor, K. M. M. Leung, J. Chew, H. Wang, S. Wang, M. G. Irwin

Summary: The amount of aerosol generation from positive pressure ventilation via supraglottic airway devices in low-risk patients was quantified and compared to aerosol levels during conversation and coughing. The study found that the aerosol concentration generated by supraglottic airway insertion and removal was significantly lower than that produced during talking and coughing. The proportion of easily inhaled and small particles was also much lower during insertion and removal compared to talking and coughing.

ANAESTHESIA (2023)

Letter Cardiac & Cardiovascular Systems

Cardioprotective and Anti-Inflammatory Effects of FAM3D in Myocardial Ischemia-Reperfusion Injury

James Rhee, Rebecca Freeman, Kangsan Roh, Margaret Lyons, Chunyang Xiao, Daniel Zlotoff, Ashish Yeri, Haobo Li, Justin Guerra, J. Sawalla Guseh, Alexandra Kuznetsov, Nicholas Houstis, Jason Roh, Federico Damilano, Xiaojun Liu, Michael Silverman, Raymond Kwong, Saumya Das, Anthony Rosenzweig

CIRCULATION RESEARCH (2023)

Review Medicine, General & Internal

New Perspective for Drug-Drug Interaction in Perioperative Period

Abigail Silva, Barbara Costa, Irene Castro, Joana Mourao, Nuno Vale

Summary: This review aims to discuss the current information on drug interactions in the perioperative period. Drug interactions during this period can affect the efficacy and safety of treatment. There are three types of drug interactions. It is important to recognize that drug interactions may increase toxicity and reduce efficacy, increasing the risk of complications. Thoroughly reviewing a patient's medication list and vigilant monitoring are essential in minimizing risks.

JOURNAL OF CLINICAL MEDICINE (2023)

暂无数据